The aim of this study is to evaluate the risk of serious adverse cardiovascular events in adolescent and adult patients with severe asthma taking tezepelumab c…

Cardiovascular EventsMACE

~Estimated

~$10 – $1,125

AstraZenecaNCT06951867

Observational

HAPPI (Hormonal Contraception Access Through Pharmacist Prescribing Implementation): Phase 2 (Aim 1)

The goal of this clinical trial is to learn if use of the HAPPI software can improve pharmacist-provided birth control services. The main questions it aims to …

ContraceptionPharmaceutical ServicesAccess and Linkage to Healthcare+1 more

~Estimated

~$10 – $8,750

EMPOWERX INCNCT06823037